Inside Deciem’s science-driven mannequin for accessible, efficient skincare

Key takeaways

• Proof-based skincare continues to underpin Deciem’s product improvement.
• The corporate has expanded its scientific capabilities with 5 in-house laboratories and over 150 specialists.
• Demand for each innovation and credible efficacy knowledge is shaping product improvement throughout the broader magnificence business.
• Scientific rigour is enabling, not limiting, creativity in formulation and ingredient exploration.

Lately, magnificence and private care customers have grow to be more and more discerning about product efficacy and the science behind components. Whereas this development spans the whole market, one disruptor model stands out for putting scientific efficacy on the centre of the wonder dialog: The Unusual, from Deciem.

The model gained consideration for spotlighting particular components – reminiscent of hyaluronic acid, azelaic acid and niacinamide – lengthy earlier than they grew to become mainstream. Introduced in pharmacy-style bottles, these merchandise provided a extra critical, dermatology-inspired method to skincare, encouraging customers to combine and match formulation based mostly on their particular person wants.

Deciem, The Unusual’s mum or dad firm, was based by Brandon Truaxe and Nicole Kilner, who got down to construct 10 manufacturers with a robust scientific ethos. In 2017, Estée Lauder Firms invested within the enterprise, and by 2021 it had absolutely acquired Deciem.

Forward of this 12 months’s in‑cosmetics International occasion in Paris, we spoke to Deciem’s Director of International Medical Analysis, Carla O’Connor, to search out out extra concerning the firm’s method to evidence-based skincare in 2026…

CosmeticsDesign-Europe (CDE): Hello Carla, what’s going to you be speaking about at this 12 months’s in‑cosmetics International?

Carla O’Connor (CO): I’ll be sharing an outline of how we method medical analysis at Deciem, together with the construction of our medical group and the kinds of testing we conduct to help our merchandise. A key focus will probably be how we decide what medical analysis is most significant, each from a scientific perspective and by way of delivering clear, credible advantages for shoppers.

I’ll define Deciem’s medical pillars and the way we mix technique improvement with each inside and exterior research to generate sturdy, substantiated claims. I’ll additionally stroll by means of a case examine from a current launch from The Unusual for example how ingredient discovery, formulation science and medical testing come collectively in follow.

CDE: Scientifically confirmed components at cheap costs have been at all times a technique for The Unusual. How has this advanced in recent times now that extra manufacturers are adopting this method?

CO: Offering scientifically supported components at wise worth factors has at all times been foundational to Deciem’s philosophy, and that hasn’t modified. What has advanced over time is the depth of our inside scientific capabilities.

We’ve considerably expanded our in-house groups (over 150 folks robust), invested in state-of-the-art laboratory infrastructure (we home our 5 labs all below one roof at our headquarters – our Analysis and Growth, Medical Analysis, Microbiology, Stability and Analytical labs), and constructed robust partnerships with trusted suppliers and analysis collaborators. We additionally conduct in depth inside opinions and ingredient audits to make sure that any ingredient we discover, whether or not well-established or rising, has significant scientific backing earlier than it strikes into improvement.

Whereas honesty and integrity stay central to our mission, we’re additionally more and more exploring newer applied sciences and subsequent‑era components. The hot button is that innovation should nonetheless be grounded in robust scientific rationale and knowledge. Our aim continues to be delivering high-quality, efficient skincare that continues to be accessible whereas pushing ahead considerate, evidence-based innovation.

CDE: Whereas there’s after all a necessity for scientific validation of ingredient claims, do you assume magnificence is liable to turning into too preoccupied with this and limiting innovation – and even eradicating the enjoyable from the class?

CO: The truth is, it’s fairly the other! The demand for each innovation and actual, seen outcomes is greater than ever, and shoppers are holding magnificence manufacturers to a a lot greater customary. Slightly than limiting creativity, this shift is pushing the business to develop merchandise that aren’t solely thrilling but in addition backed by credible proof. Customers in the present day need formulations that ship significant, perceivable advantages, and scientific validation helps make sure that what we deliver to market really works.

From the start, the premise behind The Unusual was to supply high-quality, efficient skincare at wise costs by specializing in components that already had robust scientific proof behind them. As Deciem has grown, we’ve been in a position to preserve that philosophy whereas increasing into extra novel components, rising applied sciences and multi-active formulations.

In some ways, science permits us to stay artistic. Having a robust scientific basis offers us the boldness to discover the newest components and novel applied sciences whereas making certain they’ve the info to again them up. At Deciem, innovation has at all times meant doing issues otherwise; leaning into our “Irregular Magnificence Firm” philosophy whereas nonetheless delivering merchandise that really work. For us, which means combining curiosity and experimentation with scientific rigour, so we are able to develop merchandise which can be each revolutionary and efficient for our prospects.

Carla O’Connor, Director of International Medical Analysis at Deciem, will current the session “Outcomes with integrity: The Deciem mannequin for evidence-based skincare” at in‑cosmetics International on Wednesday 15 April, 10:30–11:15 within the Advertising Traits Theatre.

In‑cosmetics International 2026 takes place from 14–16 April on the Paris Expo Porte de Versailles, France. For extra data or to register, go to the occasion web site.